By the end of March, the regulator could clear a highly anticipated pain drug from Vertex and a heart drug that’s critical to Alnylam’s future.
Scott Gottlieb and Luciana Borio, a former director for medical and biodefense preparedness policy at the National Security ...
Produce supplier Braga Fresh has issued a ‘precautionary advisory’ about the product, which is no longer in stores but might ...
Trump's staff is laying the groundwork to prepare for a new FDA commissioner and make their mark at the agency.
A discussion of the development of consumer protection law in the US through the enactment of key legislation and formation ...
The Food and Drug Administration (FDA) will begin collecting samples of raw cow’s milk cheese from across the U.S. to test ...
After plugging billions into its manufacturing network to meet rampant demand for Mounjaro and Zepbound, Eli Lilly is looking ...
Olympus advised providers to stop using an endoscope accessory due to an infection risk linked to 120 injuries and one death.
Eli Lilly is seeking to end a lawsuit filed by a pharmacy trade group against the Food and Drug Administration (FDA) by ...
Tislelizumab-jsgr (Tevimbra) was approved in combination with chemotherapy for the treatment of unresectable or metastatic ...
The agency recently sent a warning letter to the company's CEO, Valentina Milanova, noting that an inspection of the ...